What is Evogene Ltd Annual Revenue?

Evogene Ltd Annual Revenue rose 50.9%, in the last year to $8.51 M. Its sector's average revenue growth for the last fiscal year was 1.09%.

What is Evogene Ltd Annual Net Profit?

Evogene Ltd Annual Net Profit rose 30.96% in the last year to $16.48 M. Its sector's average net profit growth for the last fiscal year was -17.31%.

What is Evogene Ltd Price to Earning Ratio?

Evogene Ltd Price to Earning Ratio is -0.4, which is negative.

What is Evogene Ltd Stock Price?

Evogene Ltd Stock Price fell 84.15% and underperformed its sector by 95.72% in the past year.

What is Evogene Ltd Quarterly Revenue?

Evogene Ltd Quarterly Revenue rose 178.72% YoY to $1.61 M. Its sector's average revenue growth YoY for the quarter was 3.41%.

What is Evogene Ltd Quarterly Net profit?

Evogene Ltd Quarterly Net profit rose 106.47% YoY to $0.43 M. Its sector's average net profit growth YoY for the quarter was -51.45%.

What is Evogene Ltd Mutual Fund Holding?

Evogene Ltd Mutual Fund Holding decreased by 0% in the last quarter to 0.64.

What is Evogene Ltd Institutional Holding?

Evogene Ltd Institutional Holding remained the same in the last quarter at 6.54%.

How is the Evogene Ltd today?

The Evogene Ltd today is trading in the down by -3.00% at 0.97.

How has Evogene Ltd performed historically?

The Evogene Ltd is currently trading down -3.00% on an intraday basis in the past week the index fell -7.62%. The index has been down -45.51% in the past quarter and fell -84.15% in the past year. You can view this in the overview section.

Evogene Ltd XNAS: EVGN

Evogene Ltd Live Share Price Today, Share Analysis and Chart

Name: Evogene Ltd: Is Infosys Ltd. worth buying?
Item: Evogene Ltd
Rating: 0.54550
Author: Trendlyne DVM scores

Download real time

0.97 -0.03 (-3.00%)

89.22% Fall from 52W High

13,963 XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Evogene Ltd Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	6.6
PE TTM Negative PE TTM Unavailable in chosen country	-0.4
Price to Book Negative Price to Book Unavailable in chosen country	-4.5
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	6.5
Revenue Growth Qtr YoY % High in industry Unavailable in chosen country	178.7
Operating Revenue growth TTM % High in industry Unavailable in chosen country	50.9
Net Profit Qtr Growth YoY % High in industry Unavailable in chosen country	106.5
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	31
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-261
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-42.7

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

9.0 / 100

Technically Bearish

12.8 / 100

1Yr Price target upside is 467%

2 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Evogene Ltd Stock Price Analysis

Day Price Range -3.0% 1 Day return Unavailable in chosen country	1 (LTP) 11 LowHigh
Week Price Range -7.6% 1 Week return Unavailable in chosen country	1 (LTP) 11.1 LowHigh
Month Price Range -29.7% 1 Month return Unavailable in chosen country	1 (LTP) 11.4 LowHigh
52 Week Price Range -84.2% 1 Year return Unavailable in chosen country	1 (LTP) 0.69 LowHigh

View full Share Price History

Evogene Ltd Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Evogene Ltd's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-2.9

Avg. Estimate

-2

Low Estimate

-2.1

High Estimate

-1.8

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 30.8% in FY25

Consensus Recommendation

2 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 2 analysts for Evogene Ltd is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Evogene Ltd Stock Analysis

Evogene Ltd stock analysis with key metrics, changes, and trends.

Evogene Ltd Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$8.51 M	50.9%	positive	Annual Revenue rose 50.9%, in the last year to $8.51 M. Its sector's average revenue growth for the last fiscal year was 1.09%.
Annual Net Profit	$16.48 M	30.96%	positive	Annual Net Profit rose 30.96% in the last year to $16.48 M. Its sector's average net profit growth for the last fiscal year was -17.31%.
Price to Earning Ratio	-0.4	-	negative	Price to Earning Ratio is -0.4, which is negative.
Stock Price	$0.97	-84.15%	negative	Stock Price fell 84.15% and underperformed its sector by 95.72% in the past year.
Quarterly Revenue	$1.61 M	178.72%	positive	Quarterly Revenue rose 178.72% YoY to $1.61 M. Its sector's average revenue growth YoY for the quarter was 3.41%.
Quarterly Net profit	$0.43 M	106.47%	positive	Quarterly Net profit rose 106.47% YoY to $0.43 M. Its sector's average net profit growth YoY for the quarter was -51.45%.
Mutual Fund Holding	0.64 %	0%	negative	Mutual Fund Holding decreased by 0% in the last quarter to 0.64.
Institutional Holding	6.54 %	0%	neutral	Institutional Holding remained the same in the last quarter at 6.54%.

VIEW LESS

Loading data..

Evogene Ltd - Company Profile

What does Evogene Ltd do?

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

2024

Gross Remuneration

Year

Evogene Ltd Live Share Price Today, Share Analysis and Chart

89.22% Fall from 52W High

Evogene Ltd Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Evogene Ltd Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Evogene Ltd Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Evogene Ltd's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 30.8% in FY25

Consensus Recommendation

The consensus recommendation from 2 analysts for Evogene Ltd is STRONG BUY

Evogene Ltd Stock Analysis

Evogene Ltd stock analysis with key metrics, changes, and trends.

Annual Revenue rose 50.9%, in the last year to $8.51 M. Its sector's average revenue growth for the last fiscal year was 1.09%.

Annual Net Profit rose 30.96% in the last year to $16.48 M. Its sector's average net profit growth for the last fiscal year was -17.31%.

Price to Earning Ratio is -0.4, which is negative.

Stock Price fell 84.15% and underperformed its sector by 95.72% in the past year.

Quarterly Revenue rose 178.72% YoY to $1.61 M. Its sector's average revenue growth YoY for the quarter was 3.41%.

Quarterly Net profit rose 106.47% YoY to $0.43 M. Its sector's average net profit growth YoY for the quarter was -51.45%.

Mutual Fund Holding decreased by 0% in the last quarter to 0.64.

Institutional Holding remained the same in the last quarter at 6.54%.

Evogene Ltd - Company Profile

What does Evogene Ltd do?

Evogene Ltd Management structure

Mr. Amit Noam

Chief Executive Officer; Lavie Bio Ltd

Mr. Yoash Zohar

Chief Executive Officer; Casterra Ag Ltd.

Mr. Ofer Haviv

Director, President and Chief Executive Officer

Dr. Dan Jacob Gelvan, PhD

Chief Executive Officer; Ag Plenus Ltd.

Dr. Elran Haber, PhD

Chief Executive Officer; Biomica Ltd.

Mr. Yaron Eldad

Chief Financial Officer

Evogene Ltd Board of directors

Mr. Dan Falk

Independent Director

Mr. Leon Y. Recanati

Independent Director

Ms. Sarit Firon

Independent Director

Mr. Ofer Haviv

Director, President and Chief Executive Officer

Mr. Nir Nimrodi

Chairperson of the Board

Dr. Oded Shoseyov, PhD

Independent Director

Evogene Ltd FAQ